Alveolar Macrophage Programming Following Endotoxin Exposure

Part of paid clinical trials in Denver, Colorado.

Sponsor
National Jewish Health
Study ID
NCT03859050
Status
Recruiting

Conditions

  • ARDS, Human

Eligibility Criteria

Sex
ALL
Age
18 Years - 50 Years
Healthy Volunteers
Accepted

Interventions

  • bronchoscopy with intrabronchial administration of lipopolysaccharide — OTHER
    The PI will administer intrabronchial LPS into the lungs of healthy volunteers and then obtaining macrophages by bronchoalveolar lavage (BAL) 24, 48, 72, 96, or 120 hours later.

Study Details

The histologic hallmarks of lung inflammation include accumulation of inflammatory cells in the airspaces and interstitium, injury to alveolar epithelial and endothelial cells, loss of epithelial-capillary integrity and accumulation of edema fluid in the interstitium and airspaces. Accordingly, for alveolar repair to occur inflammation must be halted, debris and inflammatory cells removed, injured tissue cells replaced, and capillary barrier function re-established. Macrophages are key players in all of these. Here the investigators hypothesize that resident alveolar macrophages and recruited macrophages serve completely different functions, acting independently (i.e. division of labor) yet cooperatively (synergism).

Key Dates

Start date
Mar 18, 2019
Status verified
Jul 2024
Primary completion
Jul 31, 2029
Completion
Jul 31, 2032

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: LPS arm

Primary Outcome Measure

Resident alveolar macrophages and recruited macrophages will be distinguished from one another using multi-parameter flow cytometry, and the relative proportions enumerated [ Time Frame: 7 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
National Jewish HealthDenverColorado80206
Kara Mould
303-398-1787

Find similar trials in Denver, CO